Navigation Links
Verenium Appoints Holger Liepmann To Its Board Of Directors
Date:2/26/2013

Senior Vice President of International Operations of the company's ex-U.S. pharmaceutical and nutritional operations, and several other positions with Abbott International, based in various parts of the world.

Mr. Liepmann earned a bachelor's degree in Psychology from Dartmouth College and a Masters in Business Administration from Stanford University. 

About Verenium

Verenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

Forward Looking Statements

Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's ability to develop and/or commercialize its products, diversify its product portfolio, enhance its manufacturing capabilities, capture near-term and longer-term growth and prospects.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's strategic focus, technologies, products and product candidates and product pipeline (including Verenium's ability to identify, develop and commercialize new products and product candidates, either independently or with collaborators or partners, and market demand for those products and product candidates), dependence on patents and proprietary rights,  protection and enforcement of its patents and proprietary rights, the commercial prospects of the industries in which Verenium operates and sells p
'/>"/>

SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference
2. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
3. Verenium Announces $22.5 Million, Five-Year Secured Financing
4. Verenium Corporation To Announce Third Quarter 2012 Financial Results
5. Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
6. Verenium Corporation To Announce Second Quarter 2012 Financial Results
7. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
8. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
9. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
10. Verenium Corporation To Announce First Quarter 2012 Financial Results
11. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 18, 2014 LayerBio is an ... and wound care. The National Eye Institute (NEI) at ... a Phase I SBIR grant to develop a drug-eluting ... the most common cause of vision loss in people ... worldwide. According to Dr. Ken Mandell, LayerBio’s Founder and ...
(Date:12/19/2014)... The empty capsules market is experiencing growth ... technological innovations in the empty capsules market. The ... growth of the empty capsules market. , Get ... of Report , The report will enrich both ... to gauge the pulse of the market which ...
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, Inc. ... the treatment of chronic pain, announced the results of ... "This was a transformational year in Relmada,s history ... for our company," said Sergio Traversa , chief ... have executed on key financial, human resource and clinical ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... , STANFORD, Calif. In what could be a ... University research shows promise in enhancing and controlling the ... human cell cultures, potentially overcoming one of the therapy,s ... synthetic biology, an emerging field in which researchers can ...
... April 26 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE YMI, TSX:YM), ... base shelf prospectus, dated September 16, 2009 , with the Ontario ... 16, 2009 , forming part of its U.S. registration statement, with the ... , , ...
... April 26 Reportlinker.com announces that a new market research report is available in ... Future of Red Biotechnology in China ... http://www.reportlinker.com/p0189383/Future-of-Red-Biotechnology-in-China.html , ... biotechnology (RB) refers to the biotechnology applied in pharmaceutical production and it has become the ...
Cached Biology Technology:New technique reinforces immune cells that seek and destroy cancer, says Stanford researcher 2New technique reinforces immune cells that seek and destroy cancer, says Stanford researcher 3YM BioSciences announces controlled equity offering 2YM BioSciences announces controlled equity offering 3Reportlinker Adds Future of Red Biotechnology in China 2Reportlinker Adds Future of Red Biotechnology in China 3Reportlinker Adds Future of Red Biotechnology in China 4Reportlinker Adds Future of Red Biotechnology in China 5Reportlinker Adds Future of Red Biotechnology in China 6Reportlinker Adds Future of Red Biotechnology in China 7Reportlinker Adds Future of Red Biotechnology in China 8Reportlinker Adds Future of Red Biotechnology in China 9Reportlinker Adds Future of Red Biotechnology in China 10Reportlinker Adds Future of Red Biotechnology in China 11Reportlinker Adds Future of Red Biotechnology in China 12Reportlinker Adds Future of Red Biotechnology in China 13Reportlinker Adds Future of Red Biotechnology in China 14Reportlinker Adds Future of Red Biotechnology in China 15Reportlinker Adds Future of Red Biotechnology in China 16Reportlinker Adds Future of Red Biotechnology in China 17Reportlinker Adds Future of Red Biotechnology in China 18
(Date:12/3/2014)... 2014 As part of our commitment to ... pleased to announce the release of a new reader ... the workforce data that they need. The ... by existing readers. Many such devices have serious shortcomings ... technology. Older models force users to navigate numerous complicated ...
(Date:11/21/2014)... VIEW, Calif. , Nov. 20, 2014 ... higher driver efficiency are piloting the North American and ... number of accidents growing, gesture recognition systems that are ... make a mark in the industry. ... the Automotive Gesture Recognition Market in Europe ...
(Date:11/18/2014)... , Nov. 18, 2014  The Secure ... Industry Association today jointly announce the formation of ... release of its Identity and Biometric Entry ... The Framework received official support from BORDERPOL, the ... to improve and provide expertise regarding border security, ...
Breaking Biology News(10 mins):Inception Technologies to Release New Biometric Reader 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... Miss. The University of Mississippi Medical Center will ... of initiatives intended to convert laboratory discoveries into new ... An agreement between the institutions, titled ... was formally announced July 8 at UMMC during a ...
... Bio-NMR Center at the VIB Department of Molecular and Cellular ... a scientific breakthrough that made it into the leading science ... possible to determine the dynamic structure of proteins. So Flemish ... activity of certain proteins involved in the stress physiology of ...
... Defeating the flu is challenging because the virus ... genetic code, making it difficult for scientists to manufacture ... manner. Now, a University of Miami (UM) computer scientist, ... Brook University have developed a rapid and effective approach ...
Cached Biology News:UMMC and Mayo Clinic sign agreement to increase research and training 2UMMC and Mayo Clinic sign agreement to increase research and training 3Flemish researchers provide the first experimental evidence of dynamic allostery in protein regulation 2Scientists use computer algorithms to develop seasonal flu vaccines 2
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Chicken polyclonal to Thioredoxin domain containing 9 ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez Gene ID: 10190 Swiss Protein ID: O14530...
Anti-Mouse IgM Heavy Chain:FITC, Clone LO-MM-9, Monoclonal Antibody...
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: